Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.
Disability Identity Predicts Lower Anxiety and Depression in Multiple Sclerosis.
Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface.
[Diagnosis and treatment of pelvic disorders in patients with multiple sclerosis].
The fatigue-motor performance paradox in multiple sclerosis.
Spectral-Domain Optical Coherence Tomography of Retinal Nerve Fiber Layer Thickness in NMO Patients.
Initiating oral fingolimod treatment in patients with multiple sclerosis.
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination.
Unusual symptoms and syndromes in multiple sclerosis.
[New and emerging treatments for multiple sclerosis].
Phenytoin in acute optic neuritis: neuroprotective or not?
Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases.
Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents.
Endovascular Treatment of Chronic Cerebro-Spinal Venous Insufficiency in Multiple Sclerosis: A retrospective study.
Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response.
[Effects of shugan jianpi gusui recipe on multiple sclerosis recurrence: a primary report].
First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.
Expression Analysis of CB2-GFP BAC Transgenic Mice.
Myelin and macrophages in the PNS: An intimate relationship in trauma and disease.
Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.
Self-Efficacy as a Longitudinal Predictor of Perceived Cognitive Impairment in Individuals with Multiple Sclerosis.
A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort.
CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis.
Pages
« first
‹ previous
…
324
325
326
327
328
329
330
331
332
…
next ›
last »